Last updated: February 20, 2026
What is NDC 65250-0133?
NDC 65250-0133 refers to a specific drug product, which requires identification of its active ingredient, formulation, and approval status to analyze market potential accurately. Based on available public records, NDC 65250-0133 corresponds to [Specific Drug Name], developed by [Manufacturer]. This agent is approved for [indication], with a standard dosage of [dosage form and strength].
Market Landscape Overview
Therapeutic Area and Competition
The drug functions within the [specific therapeutic area], competing with [list major competitors or similar drugs]. Market analysis indicates a rising demand driven by [key factors such as aging population, unmet medical needs, regulatory approvals].
Major competitors include:
| Drug Name |
Indication |
Market Share (2022) |
Approvals/Status |
| Brand A |
[Indication] |
[X]% |
Approved, marketed |
| Generic B |
[Indication] |
[Y]% |
Approved, generic available |
| Drug C |
[Indication] |
[Z]% |
Pending approval |
Market Size and Growth
- Global Market Size: Estimated at $[value] billion in 2022, with regional breakdowns such as North America accounting for [X]%.
- Annual Growth Rate (CAGR 2023–2028): projected at [Y]%.
- Growth Drivers include increased prevalence of [disease/condition], expanded indications, and improved compliance.
Regulatory Status
- Approval Date: [Month, Year]
- Authorized Uses: [Indication details]
- Pricing and Reimbursement Frameworks: Covered under [list of payers, government programs] in key markets.
Patent and Exclusivity Timeline
- Patent expiry is expected in [year], with exclusivity periods that may extend until [year].
- Orphan drug status granted in [year], if applicable, prolongs market protection.
Price Projections
Current Pricing Overview
| Region |
Average Wholesale Price (AWP) |
2022 Price (USD) |
Notes |
| United States |
$[amount] |
$[amount] |
Based on Medispan/First Databank |
| Europe |
€[amount] |
€[amount] |
Adjusted for currency fluctuations |
Factors Influencing Price Dynamics
- Market Competition: Entry of generics reduces prices by [expected percentage] within [timeframe] of patent expiry.
- Manufacturing Costs: Influences pricing stability; raw material price changes could prompt adjustments.
- Reimbursement Policies: Reimbursement rates impact wholesale and patient prices; policy shifts could lead to increases or decreases.
- Regulatory Changes: New approvals or expanded indications could justify price revisions.
Price Trajectory Predictions (2023–2028)
| Year |
Projected Wholesale Price (USD) |
Assumptions/Comments |
| 2023 |
$[amount] |
Post-launch stabilization |
| 2024 |
$[amount] |
Competition intensifies, slight decrease |
| 2025 |
$[amount] |
Patent expiration approaching; generics enter |
| 2026 |
$[amount] |
Price drops by [X]% due to generics |
| 2027 |
$[amount] |
Stabilizes with branded or specialty pricing |
Potential Premiums for Specialty Use
If designated as a specialty drug or orphan drug, the price could maintain a premium, potentially exceeding $[amount] per unit, especially if clinical benefit is significant.
Market Entry Barriers and Opportunities
- Barriers: Patent expiration, competitive generics, payer restrictions.
- Opportunities: Extended indications, combination therapies, or new delivery formulations can support price premiums and market share expansion.
Key Takeaways
- The drug faces competition from branded and generic agents, with market penetration dependent on regulatory approvals and pricing strategies.
- Market growth is driven by increasing disease prevalence, with a CAGR forecasted at [Y]% over five years.
- Prices are expected to decline approximately [X]% post-patent expiry due to generic competition.
- The current price environment varies, with North America leading in reimbursement and pricing levels.
- Strategic positioning through expanded indications or specialty designation could sustain higher price points.
FAQs
1. When does patent expiry for NDC 65250-0133 occur?
Expected in [year], depending on patent life extensions and regulatory protections.
2. How does generic competition impact pricing?
Generics entering the market typically reduce prices by 50%–80% within 1–2 years of patent expiry.
3. Are there any upcoming regulatory decisions affecting the drug?
Regulatory agencies are scheduled to review [supplemental indications or filings] in [year] which could influence market dynamics.
4. What regional markets offer the highest revenue potential?
North America, due to its established payer systems and high prevalence of [target condition], remains the most lucrative.
5. How might emerging therapies affect this drug’s market share?
Disruptive innovations or new modalities could challenge existing agents, especially if they demonstrate superior efficacy or safety profiles.
Sources:
[1] FDA Drug Database. (2023). FDA Orange Book [Online].
[2] IQVIA Institute. (2023). The Global Use of Medicines report.
[3] EvaluatePharma. (2023). World Preview 2028.
[4] Centers for Medicare & Medicaid Services. (2023). Reimbursement policies.
[5] Company filings and patent databases.
